iCoreConnect (ICCT) AI Stock Analysis

• Market Cap: $54.14K
• Dividend Yield: N/A
• Average Volume (3M): 9.43K
• Price to Earnings (P/E): ―
• Beta (1Y): -33.65
• Revenue Growth: 31.83%
• EPS Growth: -25.30%
• Country: US
• Employees: 67
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -59.67
• Shares Outstanding: 4,877,080
• 10 Day Avg. Volume: 7,308
• 30 Day Avg. Volume: 9,429
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 287.82
• Enterprise Value/Revenue: 1.45
• Enterprise Value/Gross Profit: 2.07
• Enterprise Value/Ebitda: -0.64
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0

• Rating: 38 Underperform
• Price Target: $0.00 ▼(-100.00% Downside)

iCoreConnect faces severe financial instability, technical weakness, and negative corporate events, most notably its bankruptcy filing and delisting from Nasdaq, leading to an overall low stock score.

iCoreConnect Business Overview & Revenue Model

Company Description

iCoreConnect (ICCT) is a technology company that specializes in developing cloud-based software solutions for healthcare providers. The company offers a suite of products designed to enhance communication, improve workflow efficiency, and ensure compliance with industry regulations. Its core services include secure email, practice management software, and electronic health record (EHR) integration tools tailored to meet the unique needs of healthcare professionals.

How the Company Makes Money

iCoreConnect generates revenue primarily through the subscription-based model of its software solutions. Customers pay recurring fees for access to the company's suite of cloud-based products, which include secure communication tools and practice management systems. These services are critical for healthcare providers who need to comply with privacy laws and improve operational efficiency. Additionally, iCoreConnect may collaborate with healthcare organizations through partnerships, expanding its reach and customer base. The company also benefits from ongoing updates and support services provided to its clients, which are factored into the subscription fees.

iCoreConnect Financial Statement Overview

Summary

iCoreConnect shows significant revenue growth but struggles with profitability due to negative net income and deeply negative EBIT and EBITDA margins. The balance sheet is concerning with high leverage and negative equity, indicating financial instability. Cash flows are negative, reflecting a cash burn despite slight improvements.

Income Statement

The company shows substantial revenue growth, with a 31.9% increase in the latest year. However, net income remains negative, reflecting ongoing losses, and both EBIT and EBITDA margins are deeply negative, highlighting continued operational challenges.

Balance Sheet

The balance sheet reveals high leverage with a negative stockholders' equity, indicating financial instability. The debt-to-equity ratio is concerning due to the negative equity, and the equity ratio is negative, reflecting more liabilities than assets.

Cash Flow

Operating and free cash flows are negative, indicating cash burn. However, there was a slight improvement in free cash flow in the latest year. The high operating cash flow to net income ratio suggests cash flow is somewhat stable relative to reported losses.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	10.75M	8.15M	7.99M	4.96M	2.12M
Gross Profit	8.25M	6.12M	5.74M	3.38M	1.11M
EBITDA	-26.73M	-11.88M	-3.51M	-1.52M	-2.35M
Net Income	-31.16M	-15.55M	-7.36M	-5.80M	-3.68M
Balance Sheet
Total Assets	5.69M	15.69M	6.56M	6.63M	2.69M
Cash, Cash Equivalents and Short-Term Investments	202.18K	1.22M	196.15K	71.81K	7.62K
Total Debt	8.85M	7.88M	6.71M	3.96M	1.58M
Total Liabilities	15.49M	11.24M	9.06M	5.63M	3.32M
Stockholders Equity	-9.79M	4.44M	-2.50M	1.01M	-628.94K
Cash Flow
Free Cash Flow	-4.63M	-9.71M	-1.57M	-3.20M	-1.81M
Operating Cash Flow	-3.23M	-8.82M	-1.27M	-2.90M	-1.27M
Investing Cash Flow	-539.42K	-10.21M	-293.96K	-3.52M	-917.90K
Financing Cash Flow	2.75M	20.06M	1.69M	6.48M	1.75M

iCoreConnect Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ICCT, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.08, and below the 200-day MA of 1.59, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 41.59 is Neutral, neither overbought nor oversold. The STOCH value of 5.99 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ICCT.

iCoreConnect Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OTRKQ	38 Underperform	155.86K	>-0.01	-258.25%	―	-21.03%	47.41%
VSEE	38 Underperform	10.43M	-0.15	312105.23%	―	―	-280.85%
ICCT	38 Underperform	$54.14K	―	-1718.32%	―	31.83%	-25.30%
FOXO	22 Underperform	314.34K	―	―	―	17369.91%	69.56%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

iCoreConnect Corporate Events

iCoreConnect Files for Chapter 11 Bankruptcy

On June 2, 2025, iCoreConnect Inc. and its subsidiary filed for Chapter 11 bankruptcy to maintain control over their assets and operations while restructuring for future success. The filing aims to enhance procedural efficiency and ensure operational continuity, with outstanding note payables of over $10 million affected by the automatic stay provisions.